| Net Cash Provided by (Used in) Operating Activities |
$0 |
USD |
|
Q1 2025 |
Q1 2025 |
| Net Cash Provided by (Used in) Financing Activities |
$34,417,000 |
USD |
|
Q1 2025 |
Q1 2025 |
| Net Cash Provided by (Used in) Investing Activities |
$46,000 |
USD |
|
Q1 2025 |
Q1 2025 |
| Common Stock, Shares Authorized |
100,000 |
shares |
|
Q1 2025 |
Q1 2025 |
| Common Stock, Shares, Issued |
40 |
shares |
|
Q1 2025 |
Q1 2025 |
| Common Stock, Par or Stated Value Per Share |
0.001 |
USD/shares |
0% |
Q4 2025 |
FY 2025 |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect |
$34,463,000 |
USD |
|
Q1 2025 |
Q1 2025 |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents |
$19,904,000 |
USD |
|
Q4 2025 |
FY 2025 |
| Interest Paid, Excluding Capitalized Interest, Operating Activities |
$0 |
USD |
|
Q3 2024 |
Q3 2025 |
| Preferred Stock, Shares Authorized |
100,000,000 |
shares |
|
Q1 2025 |
FY 2025 |
| Additional Paid in Capital |
$175,234,000 |
USD |
|
Q4 2025 |
FY 2025 |
| Preferred Stock, Par or Stated Value Per Share |
0.001 |
USD/shares |
|
Q4 2025 |
FY 2025 |